0001209191-23-015875.txt : 20230303 0001209191-23-015875.hdr.sgml : 20230303 20230303175844 ACCESSION NUMBER: 0001209191-23-015875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Richard Thomas CENTRAL INDEX KEY: 0001825148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39743 FILM NUMBER: 23706350 MAIL ADDRESS: STREET 1: C/O KINNATE BIOPHARMA INC. STREET 2: 11975 EL CAMINO REAL, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kinnate Biopharma Inc. CENTRAL INDEX KEY: 0001797768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824566526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8582994699 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-01 0 0001797768 Kinnate Biopharma Inc. KNTE 0001825148 Williams Richard Thomas 103 MONTGOMERY STREET, SUITE 150 THE PRESIDIO OF SAN FRANCISCO SAN FRANCISCO CA 94129 0 1 0 0 Chief Medical Officer Common Stock 2023-03-01 4 F 0 638 5.21 D 67295 D The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of RSU's granted to the Reporting Person by the Issuer. Includes 21,875 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date. /s/ Mark A. Meltz, as attorney-in-fact 2023-03-03